+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Compounding Pharmacy Market - Global Forecast 2025-2030- Product Image
Compounding Pharmacy Market - Global Forecast 2025-2030- Product Image
Sale

Compounding Pharmacy Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 180 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6128974
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Compounding pharmacy is becoming a cornerstone of personalized medicine, supporting an adaptive approach to the delivery of customized therapies. Senior decision-makers in the healthcare and pharmaceutical sectors are closely monitoring this dynamic market, as it aligns patient needs, technological advances, and quality assurance.

Market Snapshot: Compounding Pharmacy Sector

The compounding pharmacy market demonstrates a steady growth trajectory driven by rising demand for individualized therapies and ongoing innovation in compounding technologies. As patient expectations advance, the sector captures opportunities in digitalization, process automation, and expanded therapeutic applications. Regulatory frameworks are tightening, steering product quality and consistency, while partnerships between compounding providers and healthcare institutions broaden patient access across the continuum of care.

Scope & Segmentation

This comprehensive research analyzes the compounding pharmacy market across crucial dimensions, ensuring a robust strategic overview for stakeholders.

  • Therapeutic Areas: Dermatology, hormone replacement therapy, pain management, pediatric solutions (children and adolescents, infants and toddlers, neonatal), and veterinary care (for both large and small animals).
  • Dosage Forms: Injectable drugs (intramuscular, intravenous, subcutaneous), ophthalmic solutions (eye drops, ointments), oral medications (capsules, suspensions, syrups), and topical treatments (creams, ointments, gels, lotions).
  • End User Groups: Home healthcare, hospital pharmacies, retail pharmacies, veterinary clinics.
  • Compounding Types: Non-sterile and sterile production methods, targeting varying safety and administration needs.
  • Drug Categories: Analgesics (non-opioid, opioid), antibiotics (injectable, oral, topical), cardiovascular and gastrointestinal drugs, hormone therapies (estrogen, progesterone, testosterone).
  • Regions Analyzed: Americas (United States and key states, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including select countries such as UK, Germany, UAE, and others), and Asia-Pacific (with focus on China, India, Japan, and additional markets).
  • Leading Companies Profiled: Fagron NV, Professional Compounding Centers of America, LLC, Avella Specialty Pharmacy, LLC, Central Admixture Pharmacy Services, LLC, Compound Solutions, LLC, Wedgewood Pharmacy, LLC, PharMEDium Services, Bio-Tech Pharmacal, Inc., Letco Medical, LLC, Medisca, Inc.

Key Takeaways for Senior Leadership

  • Compounding pharmacy enables tailored medication strategies that address gaps not met by standard therapies, supporting patient adherence and outcomes.
  • Digital platforms and automation are improving productivity, safety documentation, and compliance across compounding operations.
  • New regulatory guidelines emphasize risk assessment, sterility, and quality, elevating benchmarks for compounding practices industry-wide.
  • Collaboration between compounding pharmacies, prescribers, and academic partners is fueling innovation, especially in hormone, pediatric, and veterinary needs.
  • Adoption of sustainable sourcing and environmentally accountable packaging solutions is refining compounding supply chains and operational footprints.
  • Advanced technologies—like 3D printing for dosage forms and AI-driven inventory systems—are positioning key players for future differentiation.

Tariff Impact on Ingredient Sourcing

Recent United States trade measures have introduced higher tariffs on imported active pharmaceutical ingredients and specialty excipients. These changes are increasing costs along the supply chain and prompting compounding pharmacies to pursue new procurement partnerships, diversify sourcing, and optimize inventory management. Companies must closely monitor global currency shifts, which further influence pricing dynamics and risk profiles.

Compounding Pharmacy Market: Methodology & Data Sources

Research findings are generated from a multi-stage approach, blending extensive secondary data review with primary stakeholder interviews. This includes consultation with industry leaders, regulatory experts, and key healthcare practitioners. Findings are validated through quantitative surveys and triangulated for methodological reliability, ensuring that all insights reflect the current landscape of the compounding pharmacy market.

Why This Report Matters

  • Empowers executive teams to make strategic investments in modular manufacturing, compliance, and digital health integration.
  • Supports risk mitigation by mapping out procurement, supply chain, and regulatory challenges within each segment and region.
  • Enables organizations to benchmark their innovation and collaboration strategies against the industry’s top performers.

Conclusion

The compounding pharmacy market is reshaping how personalized medicines are delivered, with digital advancements and regulatory shifts at the core. Leaders who align with these trends will strengthen competitiveness and ensure sustained value for stakeholders.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Rising demand for personalized hormone replacement therapies boosting compounding pharmacy growth
5.2. Integration of advanced sterile compounding automation systems to enhance operational efficiency
5.3. Expanding veterinary compounding services to meet growing demand for customized animal medications
5.4. Growing consumer preference for preservative-free topical compounding formulations in dermatology care
5.5. Heightened regulatory scrutiny and compliance requirements shaping compounding pharmacy practices
5.6. Adoption of telepharmacy platforms enabling remote consultation and personalized medication services
5.7. Surge in interest for pediatric flavoring optimization driving adoption of compounding pharmacy solutions
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Compounding Pharmacy Market, by Therapeutic Area
8.1. Introduction
8.2. Dermatology
8.3. Hormone Replacement Therapy
8.4. Pain Management
8.5. Pediatrics
8.5.1. Children & Adolescents
8.5.2. Infants & Toddlers
8.5.3. Neonatal
8.6. Veterinary
8.6.1. Large Animal
8.6.2. Small Animal
9. Compounding Pharmacy Market, by Dosage Form
9.1. Introduction
9.2. Injectable
9.2.1. Intramuscular
9.2.2. Intravenous
9.2.3. Subcutaneous
9.3. Ophthalmic
9.3.1. Eye Drops
9.3.2. Ointments
9.4. Oral
9.4.1. Capsules
9.4.2. Suspensions
9.4.3. Syrups
9.5. Topical
9.5.1. Creams & Ointments
9.5.2. Gels & Lotions
10. Compounding Pharmacy Market, by End User
10.1. Introduction
10.2. Home Healthcare
10.3. Hospital Pharmacies
10.4. Retail Pharmacies
10.5. Veterinary Clinics
11. Compounding Pharmacy Market, by Compounding Type
11.1. Introduction
11.2. Non-Sterile
11.3. Sterile
12. Compounding Pharmacy Market, by Drug Category
12.1. Introduction
12.2. Analgesics
12.2.1. Non-Opioid
12.2.2. Opioid
12.3. Antibiotics
12.3.1. Injectable Antibiotics
12.3.2. Oral Antibiotics
12.3.3. Topical Antibiotics
12.4. Cardiovascular Drugs
12.5. Gastrointestinal Drugs
12.6. Hormones
12.6.1. Estrogen
12.6.2. Progesterone
12.6.3. Testosterone
13. Americas Compounding Pharmacy Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Compounding Pharmacy Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Compounding Pharmacy Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Fagron NV
16.3.2. Professional Compounding Centers of America, LLC
16.3.3. Avella Specialty Pharmacy, LLC
16.3.4. Central Admixture Pharmacy Services, LLC
16.3.5. Compound Solutions, LLC
16.3.6. Wedgewood Pharmacy, LLC
16.3.7. PharMEDium Services
16.3.8. Bio-Tech Pharmacal, Inc.
16.3.9. Letco Medical, LLC
16.3.10. Medisca, Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. COMPOUNDING PHARMACY MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2030 (%)
FIGURE 6. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY DOSAGE FORM, 2024 VS 2030 (%)
FIGURE 8. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY DOSAGE FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY COMPOUNDING TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY COMPOUNDING TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY DRUG CATEGORY, 2024 VS 2030 (%)
FIGURE 14. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY DRUG CATEGORY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS COMPOUNDING PHARMACY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS COMPOUNDING PHARMACY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES COMPOUNDING PHARMACY MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES COMPOUNDING PHARMACY MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA COMPOUNDING PHARMACY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA COMPOUNDING PHARMACY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC COMPOUNDING PHARMACY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC COMPOUNDING PHARMACY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. COMPOUNDING PHARMACY MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. COMPOUNDING PHARMACY MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. COMPOUNDING PHARMACY MARKET: RESEARCHAI
FIGURE 26. COMPOUNDING PHARMACY MARKET: RESEARCHSTATISTICS
FIGURE 27. COMPOUNDING PHARMACY MARKET: RESEARCHCONTACTS
FIGURE 28. COMPOUNDING PHARMACY MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. COMPOUNDING PHARMACY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY DERMATOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY DERMATOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY PEDIATRICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY PEDIATRICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY CHILDREN & ADOLESCENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY CHILDREN & ADOLESCENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY INFANTS & TODDLERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY INFANTS & TODDLERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY NEONATAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY NEONATAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY PEDIATRICS, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY PEDIATRICS, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY VETERINARY, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY VETERINARY, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY LARGE ANIMAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY LARGE ANIMAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY SMALL ANIMAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY SMALL ANIMAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY VETERINARY, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY VETERINARY, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY INJECTABLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY INTRAVENOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY OPHTHALMIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY OPHTHALMIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY EYE DROPS, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY EYE DROPS, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY OINTMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY OINTMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY OPHTHALMIC, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY OPHTHALMIC, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY CAPSULES, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY CAPSULES, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY SUSPENSIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY SUSPENSIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY SYRUPS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY SYRUPS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY TOPICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY TOPICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY CREAMS & OINTMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY CREAMS & OINTMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY GELS & LOTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY GELS & LOTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY COMPOUNDING TYPE, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY COMPOUNDING TYPE, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY NON-STERILE, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY NON-STERILE, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY STERILE, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY STERILE, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY DRUG CATEGORY, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY DRUG CATEGORY, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY ANALGESICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY ANALGESICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY NON-OPIOID, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY NON-OPIOID, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY OPIOID, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY OPIOID, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY ANALGESICS, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY ANALGESICS, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY INJECTABLE ANTIBIOTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY INJECTABLE ANTIBIOTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY ORAL ANTIBIOTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY ORAL ANTIBIOTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY TOPICAL ANTIBIOTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY TOPICAL ANTIBIOTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY CARDIOVASCULAR DRUGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY CARDIOVASCULAR DRUGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY GASTROINTESTINAL DRUGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY GASTROINTESTINAL DRUGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY HORMONES, BY REGION, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY HORMONES, BY REGION, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY ESTROGEN, BY REGION, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY ESTROGEN, BY REGION, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY PROGESTERONE, BY REGION, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY PROGESTERONE, BY REGION, 2025-2030 (USD MILLION)
TABLE 119. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY TESTOSTERONE, BY REGION, 2018-2024 (USD MILLION)
TABLE 120. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY TESTOSTERONE, BY REGION, 2025-2030 (USD MILLION)
TABLE 121. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY HORMONES, 2018-2024 (USD MILLION)
TABLE 122. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY HORMONES, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS COMPOUNDING PHARMACY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS COMPOUNDING PHARMACY MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 125. AMERICAS COMPOUNDING PHARMACY MARKET SIZE, BY PEDIATRICS, 2018-2024 (USD MILLION)
TABLE 126. AMERICAS COMPOUNDING PHARMACY MARKET SIZE, BY PEDIATRICS, 2025-2030 (USD MILLION)
TABLE 127. AMERICAS COMPOUNDING PHARMACY MARKET SIZE, BY VETERINARY, 2018-2024 (USD MILLION)
TABLE 128. AMERICAS COMPOUNDING PHARMACY MARKET SIZE, BY VETERINARY, 2025-2030 (USD MILLION)
TABLE 129. AMERICAS COMPOUNDING PHARMACY MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 130. AMERICAS COMPOUNDING PHARMACY MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 131. AMERICAS COMPOUNDING PHARMACY MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 132. AMERICAS COMPOUNDING PHARMACY MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 133. AMERICAS COMPOUNDING PHARMACY MARKET SIZE, BY OPHTHALMIC, 2018-2024 (USD MILLION)
TABLE 134. AMERICAS COMPOUNDING PHARMACY MARKET SIZE, BY OPHTHALMIC, 2025-2030 (USD MILLION)
TABLE 135. AMERICAS COMPOUNDING PHARMACY MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 136. AMERICAS COMPOUNDING PHARMACY MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 137. AMERICAS COMPOUNDING PHARMACY MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 138. AMERICAS COMPOUNDING PHARMACY MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 139. AMERICAS COMPOUNDING PHARMACY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 140. AMERICAS COMPOUNDING PHARMACY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 141. AMERICAS COMPOUNDING PHARMACY MARKET SIZE, BY COMPOUNDING TYPE, 2018-2024 (USD MILLION)
TABLE 142. AMERICAS COMPOUNDING PHARMACY MARKET SIZE, BY COMPOUNDING TYPE, 2025-2030 (USD MILLION)
TABLE 143. AMERICAS COMPOUNDING PHARMACY MARKET SIZE, BY DRUG CATEGORY, 2018-2024 (USD MILLION)
TABLE 144. AMERICAS COMPOUNDING PHARMACY MARKET SIZE, BY DRUG CATEGORY, 2025-2030 (USD MILLION)
TABLE 145. AMERICAS COMPOUNDING PHARMACY MARKET SIZE, BY ANALGESICS, 2018-2024 (USD MILLION)
TABLE 146. AMERICAS COMPOUNDING PHARMACY MARKET SIZE, BY ANALGESICS, 2025-2030 (USD MILLION)
TABLE 147. AMERICAS COMPOUNDING PHARMACY MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 148. AMERICAS COMPOUNDING PHARMACY MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 149. AMERICAS COMPOUNDING PHARMACY MARKET SIZE, BY HORMONES, 2018-2024 (USD MILLION)
TABLE 150. AMERICAS COMPOUNDING PHARMACY MARKET SIZE, BY HORMONES, 2025-2030 (USD MILLION)
TABLE 151. AMERICAS COMPOUNDING PHARMACY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 152. AMERICAS COMPOUNDING PHARMACY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 153. UNITED STATES COMPOUNDING PHARMACY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 154. UNITED STATES COMPOUNDING PHARMACY MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 155. UNITED STATES COMPOUNDING PHARMACY MARKET SIZE, BY PEDIATRICS, 2018-2024 (USD MILLION)
TABLE 156. UNITED STATES COMPOUNDING PHARMACY MARKET SIZE, BY PEDIATRICS, 2025-2030 (USD MILLION)
TABLE 157. UNITED STATES COMPOUNDING PHARMACY MARKET SIZE, BY VETERINARY, 2018-2024 (USD MILLION)
TABLE 158. UNITED STATES COMPOUNDING PHARMACY MARKET SIZE, BY VETERINARY, 2025-2030 (USD MILLION)
TABLE 159. UNITED STATES COMPOUNDING PHARMACY MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 160. UNITED STATES COMPOUNDING PHARMACY MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 161. UNITED STATES COMPOUNDING PHARMACY MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 162. UNITED STATES COMPOUNDING PHARMACY MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 163. UNITED STATES COMPOUNDING PHARMACY MARKET SIZE, BY OPHTHALMIC, 2018-2024 (USD MILLION)
TABLE 164. UNITED STATES COMPOUNDING PHARMACY MARKET SIZE, BY OPHTHALMIC, 2025-2030 (USD MILLION)
TABLE 165. UNITED STATES COMPOUNDING PHARMACY MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 166. UNITED STATES COMPOUNDING PHARMACY MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 167. UNITED STATES COMPOUNDING PHARMACY MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 168. UNITED STATES COMPOUNDING PHARMACY MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 169. UNITED STATES COMPOUNDING PHARMACY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 170. UNITED STATES COMPOUNDING PHARMACY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 171. UNITED STATES COMPOUNDING PHARMACY MARKET SIZE, BY COMPOUNDING TYPE, 2018-2024 (USD MILLION)
TABLE 172. UNITED STATES COMPOUNDING PHARMACY MARKET SIZE, BY COMPOUNDING TYPE, 2025-2030 (USD MILLION)
TABLE 173. UNITED STATES COMPOUNDING PHARMACY MARKET SIZE, BY DRUG CATEGORY, 2018-2024 (USD MILLION)
TABLE 174. UNITED STATES COMPOUNDING PHARMACY MARKET SIZE, BY DRUG CATEGORY, 2025-2030 (USD MILLION)
TABLE 175. UNITED STATES COMPOUNDING PHARMACY MARKET SIZE, BY ANALGESICS, 2018-2024 (USD MILLION)
TABLE 176. UNITED STATES COMPOUNDING PHARMACY MARKET SIZE, BY ANALGESICS, 2025-2030 (USD MILLION)
TABLE 177. UNITED STATES COMPOUNDING PHARMACY MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 178. UNITED STATES COMPOUNDING PHARMACY MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 179. UNITED STATES COMPOUNDING PHARMACY MARKET SIZE, BY HORMONES, 2018-2024 (USD MILLION)
TABLE 180. UNITED STATES COMPOUNDING PHARMACY MARKET SIZE, BY HORMONES, 2025-2030 (USD MILLION)
TABLE 181. UNITED STATES COMPOUNDING PHARMACY MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 182. UNITED STATES COMPOUNDING PHARMACY MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 183. CANADA COMPOUNDING PHARMACY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 184. CANADA COMPOUNDING PHARMACY MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 185. CANADA COMPOUNDING PHARMACY MARKET SIZE, BY PEDIATRICS, 2018-2024 (USD MILLION)
TABLE 186. CANADA COMPOUNDING PHARMACY MARKET SIZE, BY PEDIATRICS, 2025-2030 (USD MILLION)
TABLE 187. CANADA COMPOUNDING PHARMACY MARKET SIZE, BY VETERINARY, 2018-2024 (USD MILLION)
TABLE 188. CANADA COMPOUNDING PHARMACY MARKET SIZE, BY VETERINARY, 2025-2030 (USD MILLION)
TABLE 189. CANADA COMPOUNDING PHARMACY MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 190. CANADA COMPOUNDING PHARMACY MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 191. CANADA COMPOUNDING PHARMACY MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 192. CANADA COMPOUNDING PHARMACY MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 193. CANADA COMPOUNDING PHARMACY MARKET SIZE, BY OPHTHALMIC, 2018-2024 (USD MILLION)
TABLE 194. CANADA COMPOUNDING PHARMACY MARKET SIZE, BY OPHTHALMIC, 2025-2030 (USD MILLION)
TABLE 195. CANADA COMPOUNDING PHARMACY MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 196. CANADA COMPOUNDING PHARMACY MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 197. CANADA COMPOUNDING PHARMACY MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 198. CANADA COMPOUNDING PHARMACY MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 199. CANADA COMPOUNDING PHARMACY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 200. CANADA COMPOUNDING PHARMACY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 201. CANADA COMPOUNDING PHARMACY MARKET SIZE, BY COMPOUNDING TYPE, 2018-2024 (USD MILLION)
TABLE 202. CANADA COMPOUNDING PHARMACY MARKET SIZE, BY COMPOUNDING TYPE, 2025-2030 (USD MILLION)
TABLE 203. CANADA COMPOUNDING PHARMACY MARKET SIZE, BY DRUG CATEGORY, 2018-2024 (USD MILLION)
TABLE 204. CANADA COMPOUNDING PHARMACY MARKET SIZE, BY DRUG CATEGORY, 2025-2030 (USD MILLION)
TABLE 205. CANADA COMPOUNDING PHARMACY MARKET SIZE, BY ANALGESICS, 2018-2024 (USD MILLION)
TABLE 206. CANADA COMPOUNDING PHARMACY MARKET SIZE, BY ANALGESICS, 2025-2030 (USD MILLION)
TABLE 207. CANADA COMPOUNDING PHARMACY MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 208. CANADA COMPOUNDING PHARMACY MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 209. CANADA COMPOUNDING PHARMACY MARKET SIZE, BY HORMONES, 2018-2024 (USD MILLION)
TABLE 210. CANADA COMPOUNDING PHARMACY MARKET SIZE, BY HORMONES, 2025-2030 (USD MILLION)
TABLE 211. MEXICO COMPOUNDING PHARMACY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 212. MEXICO COMPOUNDING PHARMACY MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 213. MEXICO COMPOUNDING PHARMACY MARKET SIZE, BY PEDIATRICS, 2018-2024 (USD MILLION)
TABLE 214. MEXICO COMPOUNDING PHARMACY MARKET SIZE, BY PEDIATRICS, 2025-2030 (USD MILLION)
TABLE 215. MEXICO COMPOUNDING PHARMACY MARKET SIZE, BY VETERINARY, 2018-2024 (USD MILLION)
TABLE 216. MEXICO COMPOUNDING PHARMACY MARKET SIZE, BY VETERINARY, 2025-2030 (USD MILLION)
TABLE 217. MEXICO COMPOUNDING PHARMACY MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 218. MEXICO COMPOUNDING PHARMACY MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 219. MEXICO COMPOUNDING PHARMACY MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 220. MEXICO COMPOUNDING PHARMACY MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 221. MEXICO COMPOUNDING PHARMACY MARKET SIZE, BY OPHTHALMIC, 2018-2024 (USD MILLION)
TABLE 222. MEXICO COMPOUNDING PHARMACY MARKET SIZE, BY OPHTHALMIC, 2025-2030 (USD MILLION)
TABLE 223. MEXICO COMPOUNDING PHARMACY MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 224. MEXICO COMPOUNDING PHARMACY MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 225. MEXICO COMPOUNDING PHARMACY MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 226. MEXICO COMPOUNDING PHARMACY MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 227. MEXICO COMPOUNDING PHARMACY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 228. MEXICO COMPOUNDING PHARMACY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 229. MEXICO COMPOUNDING PHARMACY MARKET SIZE, BY COMPOUNDING TYPE, 2018-2024 (USD MILLION)
TABLE 230. MEXICO COMPOUNDING PHARMACY MARKET SIZE, BY COMPOUNDING TYPE, 2025-2030 (USD MILLION)
TABLE 231. MEXICO COMPOUNDING PHARMACY MARKET SIZE, BY DRUG CATEGORY, 2018-2024 (USD MILLION)
TABLE 232. MEXICO COMPOUNDING PHARMACY MARKET SIZE, BY DRUG CATEGORY, 2025-2030 (USD MILLION)
TABLE 233. MEXICO COMPOUNDING PHARMACY MARKET SIZE, BY ANALGESICS, 2018-2024 (USD MILLION)
TABLE 234. MEXICO COMPOUNDING PHARMACY MARKET SIZE, BY ANALGESICS, 2025-2030 (USD MILLION)
TABLE 235. MEXICO COMPOUNDING PHARMACY MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 236. MEXICO COMPOUNDING PHARMACY MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 237. MEXICO COMPOUNDING PHARMACY MARKET SIZE, BY HORMONES, 2018-2024 (USD MILLION)
TABLE 238. MEXICO COMPOUNDING PHARMACY MARKET SIZE, BY HORMONES, 2025-2030 (USD MILLION)
TABLE 239. BRAZIL COMPOUNDING PHARMACY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 240. BRAZIL COMPOUNDING PHARMACY MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 241. BRAZIL COMPOUNDING PHARMACY MARKET SIZE, BY PEDIATRICS, 2018-2024 (USD MILLION)
TABLE 242. BRAZIL COMPOUNDING PHARMACY MARKET SIZE, BY PEDIATRICS, 2025-2030 (USD MILLION)
TABLE 243. BRAZIL COMPOUNDING PHARMACY MARKET SIZE, BY VETERINARY, 2018-2024 (USD MILLION)
TABLE 244. BRAZIL COMPOUNDING PHARMACY MARKET SIZE, BY VETERINARY, 2025-2030 (USD MILLION)
TABLE 245. BRAZIL COMPOUNDING PHARMACY MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 246. BRAZIL COMPOUNDING PHARMACY MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 247. BRAZIL COMPOUNDING PHARMACY MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 248. BRAZIL COMPOUNDING PHARMACY MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 249. BRAZIL COMPOUNDING PHARMACY MARKET SIZE, BY OPHTHALMIC, 2018-2024 (USD MILLION)
TABLE 250. BRAZIL COMPOUNDING PHARMACY MARKET SIZE, BY OPHTHALMIC, 2025-2030 (USD MILLION)
TABLE 251. BRAZIL COMPOUNDING PHARMACY MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 252. BRAZIL COMPOUNDING PHARMACY MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 253. BRAZIL COMPOUNDING PHARMACY MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 254. BRAZIL COMPOUNDING PHARMACY MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 255. BRAZIL COMPOUNDING PHARMACY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 256. BRAZIL COMPOUNDING PHARMACY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 257. BRAZIL COMPOUNDING PHARMACY MARKET SIZE, BY COMPOUNDING TYPE, 2018-2024 (USD MILLION)
TABLE 258. BRAZIL COMPOUNDING PHARMACY MARKET SIZE, BY COMPOUNDING TYPE, 2025-2030 (USD MILLION)
TABLE 259. BRAZIL COMPOUNDING PHARMACY MARKET SIZE, BY DRUG CATEGORY, 2018-2024 (USD MILLION)
TABLE 260. BRAZIL COMPOUNDING PHARMACY MARKET SIZE, BY DRUG CATEGORY, 2025-2030 (USD MILLION)
TABLE 261. BRAZIL COMPOUNDING PHARMACY MARKET SIZE, BY ANALGESICS, 2018-2024 (USD MILLION)
TABLE 262. BRAZIL COMPOUNDING PHARMACY MARKET SIZE, BY ANALGESICS, 2025-2030 (USD MILLION)
TABLE 263. BRAZIL COMPOUNDING PHARMACY MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 264. BRAZIL COMPOUNDING PHARMACY MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 265. BRAZIL COMPOUNDING PHARMACY MARKET SIZE, BY HORMONES, 2018-2024 (USD MILLION)
TABLE 266. BRAZIL COMPOUNDING PHARMACY MARKET SIZE, BY HORMONES, 2025-2030 (USD MILLION)
TABLE 267. ARGENTINA COMPOUNDING PHARMACY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 268. ARGENTINA COMPOUNDING PHARMACY MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 269. ARGENTINA COMPOUNDING PHARMACY MARKET SIZE, BY PEDIATRICS, 2018-2024 (USD MILLION)
TABLE 270. ARGENTINA COMPOUNDING PHARMACY MARKET SIZE, BY PEDIATRICS, 2025-2030 (USD MILLION)
TABLE 271. ARGENTINA COMPOUNDING PHARMACY MARKET SIZE, BY VETERINARY, 2018-2024 (USD MILLION)
TABLE 272. ARGENTINA COMPOUNDING PHARMACY MARKET SIZE, BY VETERINARY, 2025-2030 (USD MILLION)
TABLE 273. ARGENTINA COMPOUNDING PHARMACY MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 274. ARGENTINA COMPOUNDING PHARMACY MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 275. ARGENTINA COMPOUNDING PHARMACY MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 276. ARGENTINA COMPOUNDING PHARMACY MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 277. ARGENTINA COMPOUNDING PHARMACY MARKET SIZE, BY OPHTHALMIC, 2018-2024 (USD MILLION)
TABLE 278. ARGENTINA COMPOUNDING PHARMACY MARKET SIZE, BY OPHTHALMIC, 2025-2030 (USD MILLION)
TABLE 279. ARGENTINA COMPOUNDING PHARMACY MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 280. ARGENTINA COMPOUNDING PHARMACY MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 281. ARGENTINA COMPOUNDING PHARMACY MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 282. ARGENTINA COMPOUNDING PHARMACY MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 283. ARGENTINA COMPOUNDING PHARMACY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 284. ARGENTINA COMPOUNDING PHARMACY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 285. ARGENTINA COMPOUNDING PHARMACY MARKET SIZE, BY COMPOUNDING TYPE, 2018-2024 (USD MILLION)
TABLE 286. ARGENTINA COMPOUNDING PHARMACY MARKET SIZE, BY COMPOUNDING TYPE, 2025-2030 (USD MILLION)
TABLE 287. ARGENTINA COMPOUNDING PHARMACY MARKET SIZE, BY DRUG CATEGORY, 2018-2024 (USD MILLION)
TABLE 288. ARGENTINA COMPOUNDING PHARMACY MARKET SIZE, BY DRUG CATEGORY, 2025-2030 (USD MILLION)
TABLE 289. ARGENTINA COMPOUNDING PHARMACY MARKET SIZE, BY ANALGESICS, 2018-2024 (USD MILLION)
TABLE 290. ARGENTINA COMPOUNDING PHARMACY MARKET SIZE, BY ANALGESICS, 2025-2030 (USD MILLION)
TABLE 291. ARGENTINA COMPOUNDING PHARMACY MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 292. ARGENTINA COMPOUNDING PHARMACY MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 293. ARGENTINA COMPOUNDING PHARMACY MARKET SIZE, BY HORMONES, 2018-2024 (USD MILLION)
TABLE 294. ARGENTINA COMPOUNDING PHARMACY MARKET SIZE, BY HORMONES, 2025-2030 (USD MILLION)
TABLE 295. EUROPE, MIDDLE EAST & AFRICA COMPOUNDING PHARMACY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 296. EUROPE, MIDDLE EAST & AFRICA COMPOUNDING PHARMACY MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 297. EUROPE, MIDDLE EAST & AFRICA COMPOUNDING PHARMACY MARKET SIZE, BY PEDIATRICS, 2018-2024 (USD MILLION)
TABLE 298. EUROPE, MIDDLE EAST & AFRICA COMPOUNDING PHARMACY MARKET SIZE, BY PEDIATRICS, 2025-2030 (USD MILLION)
TABLE 299. EUROPE, MIDDLE EAST & AFRICA COMPOUNDING PHARMACY MARKET SIZE, BY VETERINARY, 2018-2024 (USD MILLION)
TABLE 300. EUROPE, MIDDLE EAST & AFRICA COMPOUNDING PHARMACY MARKET SIZE, BY VETERINARY, 2025-2030 (USD MILLION)
TABLE 301. EUROPE, MIDDLE EAST & AFRICA COMPOUNDING PHARMACY MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 302. EUROPE, MIDDLE EAST & AFRICA COMPOUNDING PHARMACY MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 303. EUROPE, MIDDLE EAST & AFRICA COMPOUNDING PHARMACY MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 304. EUROPE, MIDDLE EAST & AFRICA COMPOUNDING PHARMACY MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 305. EUROPE, MIDDLE EAST & AFRICA COMPOUNDING PHARMACY MARKET SIZE, BY OPHTHALMIC, 2018-2024 (USD MILLION)
TABLE 306. EUROPE, MIDDLE EAST & AFRICA COMPOUNDING PHARMACY MARKET SIZE, BY OPHTHALMIC, 2025-2030 (USD MILLION)
TABLE 307. EUROPE, MIDDLE EAST & AFRICA COMPOUNDING PHARMACY MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 308. EUROPE, MIDDLE EAST & AFRICA COMPOUNDING PHARMACY MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 309. EUROPE, MIDDLE EAST & AFRICA COMPOUNDING PHARMACY MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 310. EUROPE, MIDDLE EAST & AFRICA COMPOUNDING PHARMACY MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 311. EUROPE, MIDDLE EAST & AFRICA COMPOUNDING PHARMACY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 312. EUROPE, MIDDLE EAST & AFRICA COMPOUNDING PHARMACY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 313. EUROPE, MIDDLE EAST & AFRICA COMPOUNDING PHARMACY MARKET SIZE, BY COMPOUNDING TYPE, 2018-2024 (USD MILLION)
TABLE 314. EUROPE, MIDDLE EAST & AFRICA COMPOUNDING PHARMACY MARKET SIZE, BY COMPOUNDING TYPE, 2025-2030 (USD MILLION)
TABLE 315. EUROPE, MIDDLE EAST & AFRICA COMPOUNDING PHARMACY MARKET SIZE, BY DRUG CATEGORY, 2018-2024 (USD MILLION)
TABLE 316. EUROPE, MIDDLE EAST & AFRICA COMPOUNDING PHARMACY MARKET SIZE, BY DRUG CATEGORY, 2025-2030 (USD MILLION)
TABLE 317. EUROPE, MIDDLE EAST & AFRICA COMPOUNDING PHARMACY MARKET SIZE, BY ANALGESICS, 2018-2024 (USD MILLION)
TABLE 318. EUROPE, MIDDLE EAST & AFRICA COMPOUNDING PHARMACY MARKET SIZE, BY ANALGESICS, 2025-2030 (USD MILLION)
TABLE 319. EUROPE, MIDDLE EAST & AFRICA COMPOUNDING PHARMACY MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 320. EUROPE, MIDDLE EAST & AFRICA COMPOUNDING PHARMACY MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 321. EUROPE, MIDDLE EAST & AFRICA COMPOUNDING PHARMACY MARKET SIZE, BY HORMONES, 2018-2024 (USD MILLION)
TABLE 322. EUROPE, MIDDLE EAST & AFRICA COMPOUNDING PHARMACY MARKET SIZE, BY HORMONES, 2025-2030 (USD MILLION)
TABLE 323. EUROPE, MIDDLE EAST & AFRICA COMPOUNDING PHARMACY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 324. EUROPE, MIDDLE EAST & AFRICA COMPOUNDING PHARMACY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 325. UNITED KINGDOM COMPOUNDING PHARMACY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 326. UNITED KINGDOM COMPOUNDING PHARMACY MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 327. UNITED KINGDOM COMPOUNDING PHARMACY MARKET SIZE, BY PEDIATRICS, 2018-2024 (USD MILLION)
TABLE 328. UNITED KINGDOM COMPOUNDING PHARMACY MARKET SIZE, BY PEDIATRICS, 2025-2030 (USD MILLION)
TABLE 329. UNITED KINGDOM COMPOUNDING PHARMACY MARKET SIZE, BY VETERINARY, 2018-2024 (USD MILLION)
TABLE 330. UNITED KINGDOM COMPOUNDING PHARMACY MARKET SIZE, BY VETERINARY, 2025-2030 (USD MILLION)
TABLE 331. UNITED KINGDOM COMPOUNDING PHARMACY MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 332. UNITED KINGDOM COMPOUNDING PHARMACY MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 333. UNITED KINGDOM COMPOUNDING PHARMACY MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 334. UNITED KINGDOM COMPOUNDING PHARMACY MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 335. UNITED KINGDOM COMPOUNDING PHARMACY MARKET SIZE, BY OPHTHALMIC, 2018-2024 (USD MILLION)
TABLE 336. UNITED KINGDOM COMPOUNDING PHARMACY MARKET SIZE, BY OPHTHALMIC, 2025-2030 (USD MILLION)
TABLE 337. UNITED KINGDOM COMPOUNDING PHARMACY MARK

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Compounding Pharmacy market report include:
  • Fagron NV
  • Professional Compounding Centers of America, LLC
  • Avella Specialty Pharmacy, LLC
  • Central Admixture Pharmacy Services, LLC
  • Compound Solutions, LLC
  • Wedgewood Pharmacy, LLC
  • PharMEDium Services
  • Bio-Tech Pharmacal, Inc.
  • Letco Medical, LLC
  • Medisca, Inc.

Related Topics

Related Reports

Compounding Pharmacies Market - Global Forecast 2025-2030 - Product Image

Compounding Pharmacies Market - Global Forecast 2025-2030

  • Report
  • 186 Pages
  • Global
From
Compounding Pharmacy - Global Strategic Business Report - Product Image

Compounding Pharmacy - Global Strategic Business Report

  • Report
  • 187 Pages
  • Global
From
Sterile Compounding Pharmacies Market Report 2025 - Product Image

Sterile Compounding Pharmacies Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Compounding Pharmacy - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030) - Product Image

Compounding Pharmacy - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)

  • Report
  • 110 Pages
  • Global
From
Compounding Pharmacies Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Image

Compounding Pharmacies Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • 260 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.